Similar Items: Comparison of a multi‐analyte algorithmic immunoassay blood test with immunoprecipitation mass spectrometry for the detection of amyloid pathology
- Performing multiple biomarker tests delays initiation of amyloid‐targeting treatments
- Relationships between longitudinal retinal amyloid imaging and amyloid PET in the A4 Trial
- Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
- Anti‐amyloid nanobody‐Fc fusion protein drives potent amyloid clearance through microglial recruitment
- Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology
- Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS